Phase change material for thermotherapy of Buruli Ulcer: A prospective observational single centre proof-of-principle trial

PLoS Neglected Tropical Diseases

Volumn 3, Issue 2, 2009, Pages

  Junghanss, Thomas ^a   Boock, Alphonse Um ^b   Vogel, Moritz ^a   Schuette, Daniela ^c   Weinlaeder, Helmut ^d   Pluschke, Gerd ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Leprosy Relief Emmaus Switzerland (ALES) Cameroon   (Cameroon)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d BAVARIAN CENTER FOR APPLIED ENERGY RESEARCH ZAE BAYERN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID;

ADOLESCENT; ADULT; ARTICLE; BURULI ULCER; CAMEROON; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; MALE; OBSERVATIONAL STUDY; PATIENT SAFETY; PROSPECTIVE STUDY; RELAPSE; SKIN DEFECT; SKIN INFLAMMATION; SKIN TRANSPLANTATION; THERAPY EFFECT; ULCER HEALING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BURULI ULCER; CHILD; HUMANS; HYPERTHERMIA, INDUCED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65549150805     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000380     Document Type: Article

References (18)

1. Johnson PD, Stinear T, Small PL, Pluschke G, Merritt RW, et al. (2005) Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med 2: e108. doi:10.1371/journal.pmed.0020108.
2. Hayman J (1993) Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol 46: 5-9.
3. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854-857.
4. Walsh SD, Portaels F, Meyers WM (2008) Buruli ulcer (Mycobacterium ulcerans infection). Trans R Soc Trop Med Hyg 102: 969-978.
5. Sizaire V, Nackers F, Comte E, Portaels F (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6: 288-296.
6. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
7. WHO (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization, Geneva, Switzerland.
8. Chauty A, Ardant MF, Adeye A, Euverte H, Guedenon A, et al. (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51: 4029-4035.
9. Eddyani M, Portaels F (2007) Survival of Mycobacterium ulcerans at 37 degrees C. Clin Microbiol Infect 13: 1033-1035.
10. Meyers WM, Shelly WM, Connor DH (1974) Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg 23: 924-929.
11. WHO (2000) Buruli Ulcer (eds. K Asiedu, R Scherpbier, M Raviglione) WHO/ CDS/CPE/GBUI/2000.1.
12. WHO (2001) Buruli Ulcer. Diagnosis of Mycobacterium ulcerans disease (eds F Portaels, P Johnson, WM Meyers). WHO/CDS/CPE/GBUI/2001.4.
13. Meleney FL, Johnson BA (1950) Supplementary report on the case of chronic ulceration of the foot due to a new pathogenic mycobacterium (MacCallum). Ann Soc Belg Med Trop 30: 1499-1503.
14. Glynn PJ (1972) The use of surgery and local temperature elevation in mycobacterium ulcerans infection. Aust N Z J Surg 41: 312-317.
15. Reid IS (1967) Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby General Hospital, Papua. Med J Aust 1: 427-431.
16. Schuette D, Um-Boock A, Mensah-Quainoo E, Itin P, Schmid P, et al. (2007) Development of highly organized lymphoid structures in buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl Trop Dis 1: e2. doi:10.1371/journal.pntd.0000002.
17. Lipman M, Breen R (2006) Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 19: 20-25.
18. Waldorf H, Fewkes J (1995) Wound healing. Adv Dermatol 10: 77-96; discussion 97.